NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – Sildenafil (Viagra) is associated with a number of side effects, but data on long-term harms are still lacking, a systematic review and meta-analysis…
NEW YORK (Reuters Health) – In non-diabetic patients with hypertensive kidney disease, the risk of hyperkalemia with angiotensin converting enzyme (ACE) inhibitors is “small,” according to research reported…
NEW YORK (Reuters Health) – Treatment of mild gestational diabetes mellitus (GDM) cut the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders in a study…
NEW YORK (Reuters Health) – Women who become mothers are more likely to develop the metabolic syndrome during middle age than are their nulliparous counterparts, prospective study findings…
NEW YORK (Reuters Health) – Diabetes is an independent risk factor for atrial fibrillation in women, U.S. investigators report in the October issue of Diabetes Care. The disease…
NEW YORK (Reuters Health) – In older patients with stable coronary disease, adding percutaneous coronary intervention (PCI) to optimal medical therapy neither improves nor worsens their outcomes, new…
NEW YORK (Reuters Health) – Excessive intake of fructose can increase blood pressure and induce other features of the metabolic syndrome, according to study findings presented Wednesday at…
NEW YORK (Reuters Health) – Amlodipine-based therapy is still a better treatment for uncomplicated hypertension than atenolol-based therapy, even in patients with higher baseline heart rates, according to…
NEW YORK (Reuters Health) – Darusentan, a selective endothelin-receptor blocker, can reduce blood pressure in patients who have not reached their target levels using three or more antihypertensive…